Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
06160
06160
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest 06160 ETF News Today | Earnings, Events & Price Alerts
06160 News
CLSA Lowers BEONE MEDICINES (06160.HK) Price Target to $286.2 Following 4Q25 Net Profit Disappointment
1d ago
aastocks
CICC Identifies Possible 'Blue Chip' Stocks for HSI Semi-Annual Adjustment Predictions (Table)
Jan 19 2026
aastocks
CICC Forecasts Inclusion of ZIJIN GOLD INTL, BEONE MEDICINES, PICC P&C, and AKESO in HSI; STANCHART Likely to Take HANG SENG BANK's Place
Jan 19 2026
aastocks
BEONE MEDICINES' 'Baiyue Da' Achieves First Sales Transaction in Beijing
Jan 15 2026
aastocks
HSI Rises 123 Points at Opening; Pharmaceutical Stocks Surge; HAIDILAO Jumps Over 5%
Jan 14 2026
aastocks
HKEX Introduces Six New Classes of Stock Options
Jan 09 2026
aastocks
BeOne Reports ZIIHERA Trial Results, Significant Survival Improvement Observed
Jan 06 2026
Businesswire
BeOne Medicines to Present at 2026 J.P. Morgan Healthcare Conference
Dec 23 2025
Yahoo Finance
China's NRDL Set to Launch Next Year; BEONE MEDICINES Secures Two Drugs on Shortlist
Dec 08 2025
aastocks
BeOne Medicines Presents 52.4% Efficacy of Sonrotoclax at ASH Meeting
Dec 07 2025
Businesswire
BeOne's Sonrotoclax Shows Significant Efficacy in MCL and CLL Treatments
Dec 07 2025
Newsfilter
BeOne Medicines' Sonrotoclax Receives FDA Priority Review for R/R MCL Treatment
Nov 26 2025
Newsfilter
<Midday Update> HSI Falls 340 Points; HSTI Declines 131 Points; BABA Drops More Than 3%; WH GROUP and BOSIDENG Reach New Peaks
Nov 14 2025
aastocks
CICC Increases BEONE MEDICINES' Target Price to HKD250; Maintains Outperform Rating
Nov 13 2025
aastocks
<Research> BOCOMI Increases Price Target for BEONE MEDICINES (06160.HK) to $231 Following Promising New Pipeline Developments
Nov 11 2025
aastocks
CCBI Raises BEONE MEDICINES (06160.HK) Price Target to $234 Following Strong 3Q Results, Maintains Outperform Rating
Nov 10 2025
aastocks
Show More News
